Drug recall · October 21, 2026
Hydrocortisone Sodium Succinate for Injection recall
Why: Failed Impurities/Degradation Specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1.
- Lots / codes
Lot #: LB00047A, LB00048A, Exp. Date 03/2028
- Quantity
- 70776 vials
- Company
- Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
- Distribution
- Nationwide within the United States
- Initiated
- October 1, 2026 · Voluntary: Firm initiated
- Classified
- October 13, 2026
- Reported
- October 21, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrocortisone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.